4//SEC Filing
BURNETT JOSEPH 4
Accession 0001193125-26-011866
CIK 0001285550other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:00 PM ET
Size
10.3 KB
Accession
0001193125-26-011866
Insider Transaction Report
Form 4
BURNETT JOSEPH
DirectorCEO and President
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-09$2.50/sh+20,000$50,000→ 31,565 total - Sale
Common Stock
[F1][F2]2026-01-09$16.12/sh−20,000$322,400→ 11,565 total - Exercise/Conversion
Stock Options (right to buy)
[F1][F4]2026-01-09−20,000→ 330,000 totalExercise: $2.50Exp: 2027-11-07→ Common Stock (20,000 underlying)
Holdings
- 217,059(indirect: See Footnote)
Common Stock
[F3]
Footnotes (4)
- [F1]The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.
- [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $15.88 to $16.43. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
- [F4]The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017.
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett|2026-01-13
Documents
Issuer
ClearPoint Neuro, Inc.
CIK 0001285550
Entity typeother
Related Parties
1- filerCIK 0001721010
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:00 PM ET
- Size
- 10.3 KB